JP Morgan Chase’s Nightstar Therapeutics NITE Stock Holding History
Bought
Maintained
Sold
JP Morgan Chase's NITE Position: Q2 2019 in Review
JP Morgan Chase sold out of Nightstar Therapeutics (NITE) in Q2 2019, closing a stake of 12,066 shares — an estimated $306K sold.
JP Morgan Chase first reported a position in NITE in Q3 2018 and held it in 3 quarters. The position peaked at $306K in Q1 2019. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.
- JP Morgan Chase reported no remaining Nightstar Therapeutics position as of Q2 2019 after selling out during the quarter.
- JP Morgan Chase sold 12,066 Nightstar Therapeutics shares in Q2 2019, an estimated $306K.
- JP Morgan Chase first reported a position in Nightstar Therapeutics in Q3 2018 and held it in 3 quarters.
- JP Morgan Chase's Nightstar Therapeutics position peaked at $306K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Nightstar Therapeutics as of Q2 2019.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.